MedTrace Logo

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

NCT02304913 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-04-14

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Conditions

  • Acupuncture
  • Taste Disorders
  • Dysgeusia
  • Chemotherapy
  • Cancer

Interventions

OTHER

Hypoglossal acupuncture

OTHER

Sham acupuncture

BEHAVIORAL

Dietary recommendations

Sponsors & Collaborators

  • Universität Duisburg-Essen

    lead OTHER

Principal Investigators

  • Gustav Dobos, Prof., MD · Center for Integrative Medicine and Health, University Hospital Essen, University of Duisburg-Essen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02304913 on ClinicalTrials.gov